Castro André Peres Barbosa de, Moreira Marina Figueiredo, Bermejo Paulo Henrique de Souza, Rodrigues Waldecy, Prata David Nadler
Department of Strategic Articulation of Health Surveillance, Secretariat of Health Surveillance, Ministry of Health, Brasília 70719-040, Brazil.
Faculty of Economics, Administration, Accounting and Information Science, University of Brasilia, Brasília 70910-900, Brazil.
Int J Environ Res Public Health. 2021 Jul 18;18(14):7626. doi: 10.3390/ijerph18147626.
In November 2020, Brazil ranked third in the number of cases of coronavirus disease 2019 (COVID-19) and second in the number of deaths due to the disease. We carried out a descriptive study of deaths, mortality rate, years of potential life lost (YPLL) and excess mortality due to COVID-19, based on SARS-CoV-2 records in SIVEP-Gripe (Ministry of Health of Brazil) from 16 February 2020, to 1 January 2021. In this period, there were 98,025 deaths from COVID-19 in Brazil. Men accounted for 60.5% of the estimated 1.2 million YPLLs. High YPLL averages showed prematurity of deaths. The population aged 45-64 years (both sexes) represented more than 50% of all YPLLs. Risk factors were present in 69.5% of deaths, with heart disease, diabetes and obesity representing the most prevalent comorbidities in both sexes. Indigenous people had the lowest number of deaths and the highest average YPLL. However, in indigenous people, pregnant women and mothers had an average YPLL of over 35 years. The excess mortality for Brazil was estimated at 122,914 deaths (9.2%). The results show that the social impacts of YPLL due to COVID-19 are different depending on gender, race and risk factors. YPLL and excess mortality can be used to guide the prioritization of health interventions, such as prioritization of vaccination, lockdowns, or distribution of facial masks for the most vulnerable populations.
2020年11月,巴西的2019冠状病毒病(COVID-19)病例数位居世界第三,该病死亡人数位居世界第二。我们基于巴西卫生部SIVEP-Gripe系统中2020年2月16日至2021年1月1日的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)记录,对COVID-19导致的死亡、死亡率、潜在寿命损失年数(YPLL)和超额死亡率进行了描述性研究。在此期间,巴西有98,025人死于COVID-19。在估计的120万潜在寿命损失年数中,男性占60.5%。较高的潜在寿命损失年数平均值表明死亡具有过早性。45至64岁的人群(无论男女)占所有潜在寿命损失年数的50%以上。69.5%的死亡病例存在风险因素,心脏病、糖尿病和肥胖是男女中最常见的合并症。原住民的死亡人数最少,但潜在寿命损失年数平均值最高。然而,在原住民中,孕妇和母亲的潜在寿命损失年数平均值超过35年。巴西的超额死亡率估计为122,914人死亡(9.2%)。结果表明,COVID-19导致的潜在寿命损失年数的社会影响因性别、种族和风险因素而异。潜在寿命损失年数和超额死亡率可用于指导卫生干预措施的优先排序,例如为最脆弱人群优先接种疫苗、实施封锁或分发口罩。